Results 31 to 40 of about 176,126 (218)

Diuretic Resistance [PDF]

open access: yesAmerican Journal of Kidney Diseases, 2017
Diuretic resistance is defined as a failure to achieve the therapeutically desired reduction in edema despite a full dose of diuretic. The causes of diuretic resistance include poor adherence to drug therapy or dietary sodium restriction, pharmacokinetic issues, and compensatory increases in sodium reabsorption in nephron sites that are not blocked by ...
Hoorn, Ewout, Ellison, DH
openaire   +3 more sources

Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme [PDF]

open access: yes, 2016
Aims We investigated the association between worsening renal function (WRF) that occurs during renin–angiotensin–aldosterone system inhibition initation and outcome in heart failure (HF) patients with preserved ejection fraction (HFPEF) and compared ...
Brenner   +21 more
core   +1 more source

Controlled arterial hypertension and adverse event free survival rate in heart recipients

open access: yesКардиоваскулярная терапия и профилактика, 2018
Aim. To evaluate the prevalence of arterial hypertension (AH) in heart transplant recipients, and its influence on the risk of adverse events, as the efficacy and safety of antihypertension medications (AHM).Material and methods.
A. О. Shevchenko   +4 more
doaj   +1 more source

Pharmacotherapy for Essential Hypertension: A Brief Review

open access: yesMethodist DeBakey Cardiovascular Journal, 2022
Hypertension is one of the leading causes of disability-adjusted life years and mortality, with approximately 15% prevalence worldwide. Most patients with hypertension from low- to high-income countries do not receive treatment.
Behnam Heidari   +2 more
doaj   +1 more source

Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV Trial

open access: yesKidney Diseases
Introduction: VERTIS CV was a placebo-controlled cardiovascular (CV) outcome trial evaluating the sodium-glucose cotransporter 2 inhibitor ertugliflozin in patients with type 2 diabetes and established atherosclerotic CV disease.
David Z.I. Cherney   +10 more
doaj   +1 more source

The effects of short-term omission of daily medication on the pathophysiology of heart failure [PDF]

open access: yes, 2016
Aims Pharmacological therapies for heart failure (HF) aim to improve congestion, symptoms, and prognosis. Failing to take medication is a potential cause of worsening HF.
Abraham   +31 more
core   +4 more sources

Association of diuretics with falls and wrist fractures: a Mendelian randomization study

open access: yesFrontiers in Public Health
BackgroundThe association between diuretics and falls in older adult has been reported in previous studies, but discrepancy remains between the different types of diuretics.
Fei Liu   +5 more
doaj   +1 more source

Diuretics for hypertension from the perspective of novel clinical guidelines and meta-analyzes

open access: yesРоссийский кардиологический журнал, 2021
A review of the efficacy and safety of diuretics in hypertension was carried out from the standpoint of current clinical guidelines. Also, updated data from metaanalyzes of the efficacy and metabolic effects of diuretic therapy were reviewed.
S. V. Nedogoda
doaj   +1 more source

Management of hyperkalemia in the acutely ill patient. [PDF]

open access: yes, 2019
PURPOSE:To review the mechanisms of action, expected efficacy and side effects of strategies to control hyperkalemia in acutely ill patients. METHODS:We searched MEDLINE and EMBASE for relevant papers published in English between Jan 1, 1938, and July 1,
Dépret, François   +5 more
core   +3 more sources

Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout

open access: yesArthritis Care &Research, EarlyView.
Objective Body mass index (BMI), glomerular filtration rate (GFR), and pretreatment urate levels have been reported to influence the urate‐lowering response to allopurinol. We investigated whether the fractional excretion of uric acid (FEUA) also modulates this response and relates to oxypurinol concentrations.
Pascal Richette   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy